TrialAnnals of hematology2014
Bendamustine combined with rituximab for patients with relapsed or refractory diffuse large B cell lymphoma.
Jeffrey L Vacirca et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
38 papers cite it
this paperpooled ittrialcites it